Drug class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Antiviral
Mechanism of action
Nucleoside Reverse Transcriptase Inhibitors [MoA]
General use cases
- Hepatitis B, Chronic
- chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
